NNVC
NANOVIRICIDES, INC.
Key Financials
Net Income
$-8218509
↑ 13.2%
Revenue
$0
N/A
Operating Income
$-8306361
↑ 13.4%
EPS (Diluted)
$-0.41
↑ 34.9%
Shareholders' Equity
$8.7M
↑ 15.5%
Total Liabilities
$1.2M
↓ 7.7%
Total Assets
$9.9M
↑ 11.9%
Cash & Equivalents
$2.8M
↑ 79.3%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| DEF 14A | 10/8/2026 | View on SEC |
| 8-K | 9/29/2026 | View on SEC |
| 10-K | 9/28/2026 | View on SEC |
| 424B3 | 9/3/2026 | View on SEC |
| EFFECT | 8/31/2026 | View on SEC |
| S-3 | 8/21/2026 | View on SEC |
| 8-K | 7/30/2026 | View on SEC |
| 424B5 | 7/27/2026 | View on SEC |
| 424B5 | 7/27/2026 | View on SEC |
| 8-K | 7/17/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | NNVC |
| Company Name | NANOVIRICIDES, INC. |
| CIK | 1379006 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | NYSE |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 0630 |
| State of Incorporation | DE |
| Phone | (203) 668-5580 |